TCL Archive Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill May 9, 2014
TCL Archive Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year. January 26, 2001
TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. October 8, 2004
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive With NIH “Accountability” As Background, Advocates Support Budget Increases. March 30, 2001